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Abstract Bacterial infections are the second largest cause of
mortality in shrimp hatcheries. Among them, bacteria from the
genus Vibrio constitute a major threat. As the use of antibiotics
may be ineffective and banned from the food sector, alterna-
tives are required. Historically, phage therapy, which is the use
of bacteriophages, is thought to be a promising option to fight
against bacterial infections. However, as for antibiotics, resis-
tance can be rapidly developed. Since the emergence of resis-
tance is highly undesirable, a formal characterization of the
dynamics of its acquisition is mandatory. Here, we explored the
co-evolutionary dynamics of resistance between the bacteria
Vibrio sp. CV1 and the phages V1G, V1P1, and V1P2. Single-
phage treatments as well as a cocktail composed of the three
phages were considered. We found that in the presence of a
single phage, bacteria rapidly evolved resistance, and the
phages decreased their infectivity, suggesting that monotherapy
may be an inefficient treatment to fight against Vibrio infec-
tions in shrimp hatcheries. On the contrary, the use of a phage
cocktail considerably delayed the evolution of resistance and
sustained phage infectivity for periods in which shrimp larvae
are most susceptible to bacterial infections, suggesting the
simultaneous use of multiple phages as a serious strategy for
the control of vibriosis. These findings are very promising in
terms of their consequences to different industrial and medical
scenarios where bacterial infections are present.
Introduction
Aquaculture in marine environments is one of the fastest
growing food production sectors worldwide [1]. However,
the marine environment supports a broad variety of bacterial
pathogens threatening the survival of marine animals and thus
negatively influencing food production [2]. To prevent such
bacterial infections, the prophylactic use of antibiotics (AB) is
widespread, but several concerns arise from this practice.
First, while laboratory trials have demonstrated the effective-
ness of AB against bacterial infections, field studies show less
satisfactory results [3, 4]. Second, there is evidence regarding
the emergence of AB resistance [2, 5, 6], and third, the
presence of AB residuals on animal tissue that will eventually
reach human consumers may help develop AB resistance
among opportunistic human pathogens [2, 4]. These consid-
erations have lead the use of AB to be unsuitable and restricted
from aquaculture systems, generating the need for developing
new alternatives to control bacterial infections.
Over the last decade, the use of bacteriophages (phages),
viruses that specifically infect bacteria and act as their natural
predators [7–9], has reemerged as an alternative method to
fight against bacterial infections in diverse industrial contexts
[10–16]. However, as for antibiotics, bacteria may evolve
resistance [17]. Thus, in order to use phage therapy as an
efficient method for the control of bacterial infections, a
detailed evaluation of the dynamics of resistance and infectiv-
ity is needed [18, 19]. Controlled laboratory experiments have
revealed that the long-term interaction between bacteria and
phage may result in a dynamic process of infection and the
development of resistance [20–26], forcing both organisms to
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rapidly evolve and allowing them to stably co-exist. Those
dynamics of co-existence have been described as a model of
antagonistic co-evolution in which a permanent evolutionary
arms race takes place [22, 23, 25, 26]. Susceptible bacteria
generate or activate a resistance mechanism and grow in spite
of the pressure exerted by the phage. As the resistance spreads
through the bacterial population, the susceptibility diminishes;
meanwhile, newly evolved phages emerge and overcome the
resistance barrier. The antagonistic co-evolutionary theory
suggests that bacterial populations may be less susceptible to
phages they have met in the past while more susceptible to
those they have not yet meet [22, 23]. In other cases, if phages
evolve faster than their host bacteria, they can get specialized
on their contemporary hosts and be better adapted to their
contemporary hosts compared to past and future hosts [27].
Alternatively, the long-term co-existence of phage and bacte-
ria may not be possible if all bacteria become resistant or all
bacteria are susceptible [28]. Thus, the experimental study of
the long-term dynamics of resistance is not only necessary for
the formal characterization of the bacteria/phage interaction; it
may also provide valuable information to the advantage of
phage therapy [29].
In shrimp hatcheries (Penaeus monodon and Litopenaeus
vannamei), one of the most common bacterial infections
is caused by luminescent bacteria from the genus Vibrio (i.e.,
Vibrio harveyi ,Vibrio campbellii , andVibrio parahaemolyticus)
that produces a significant increase in shrimp mortality
especially during larval stages [14, 30–32]. While phage
therapy represents a promising strategy for controlling bac-
terial infections in shrimp hatcheries [4, 13, reviewed by 14,
33], the long-term dynamics between bacteria and phages
has not been elucidated, and not much is known on the
acquisition of resistance. For phage therapy purposes, the
characterization of the evolutionary dynamics is crucial to
find how quickly the resistance appears and, given the case,
how long it takes the phage to regain infectivity. Moreover,
as a strategy to increase the success of phage therapy, the
simultaneous incorporation of multiple phages (cocktail)
has been recently implemented [16, 17, 34–39]. The use
of phage cocktails may not only augment the spectrum of
antimicrobial activity but may also decrease or delay the
evolution to resistance [34, 36, 38]. The rationale is that the
probability of multiple independent resistance mutations to
occur is lower than that of a single mutation. Additionally,
the development of multi-resistance may be accompanied
by a higher cost for the bacteria.
The main goal of this study was to experimentally evaluate
the co-evolutionary dynamics of Vibrio sp. CV1 and three
lytic phages V1G, V1P1, and V1P2 in order to characterize
the emergence of resistance and explore the most suitable
conditions to increase phage therapy success. We also ex-
plored the co-evolutionary response of bacterial resistance to
a phage cocktail composed of the three phages.
Materials and Methods
Microorganisms
Researchers at the Research Center for the Aquaculture in
Colombia (CENIACUA) (Cartagena, Colombia) isolated the
Vibrio sp. strain CV1 from infected larvae of the white shrimp
Litopenaeus setiferus that was reported to be lethal for the
crustacean (communication from CENIACUA). Taxonomic
confirmation of the bacterial isolate was done through the
amplification and sequencing of the 16S rRNA gene
(MACROGEN Inc., #60-24, Gasan-dong, Geumchen-gu,
Seoul, South Korea). Isolation of phages was carried out
by selective enrichment of the sediment samples from
CENIACUA's shrimp hatcheries in 30 ml LB broth in which
the Vibrio sp. CV1 was previously inoculated and statically
incubated for 24 h at 30 °C. After incubation, the enriched
culture was centrifuged (8,500 rpm for 30 min) and filtered
(0.22-μm pore size) for serial plating and incubation (24 h at
30 °C). Three phages (hereafter named V1G, V1P1, and V1P2)
were isolated based in plaque size and morphology only
(no electron microscopy or host range tests were performed)
and purified until pure single plaques were obtained. Each
phage was able to significantly reduce Vibrio sp. CV1 counts.
Each phage was concentrated by ultracentrifugation (20,000×g
for 1 h), and high titer stocks were stored at 4 °C in SM buffer
(for 1,000ml 50mMTris–HCl, 100mMNaCl, 8 mMMgSO×
7H2O, and 5 ml gelatin 2 %) until used.
Individual Phage Co-Evolution Experiment
In this experiment, phages V1G, V1P1, and V1P2 were indi-
vidually cultured with the bacteria Vibrio sp. CV1 and prop-
agated together for 12 days, allowing both organisms to co-
evolve. It has been shown that this is the period of time in
which Vibrio counts increase the most and reach a steady state
in infected tanks containing shrimp larvae [14]. Prior to the
experiment, Vibrio sp. CV1 was activated in Luria–Bertani
(LB) broth for 20 h at 30 °C, and the phages were suspended
in a highly concentrated stock. To initiate the experiment, six
25-ml glass vials containing 6 ml of LB broth were inoculated
with 106 cells ofVibrio sp. CV1 and 107 viral particles of each
phage separately as described in Buckling and Rainey [22].
The six replicates of each bacteria–phage cultures were prop-
agated into fresh broth (hereafter transfer) every 48 h for a
total of 12 days (five transfers). At each transfer and at the end
of the experiment, five bacterial isolates were randomly pick-
ed from each replicate culture after plating in the LB agar,
and one phage isolate was collected after centrifugation
(8,500 rpm for 30 min) with 0.1 vol chloroform and filtered
through a 0.22-μm disposable filter. Overall, for each bacte-
ria–phage culture replicate, we collected 30 bacterial and 6
phage isolates per transfer and stored them at −80 and 4 °C,
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respectively, until the end of the experiment to perform
resistance/infection tests (described below). In total, 540 bac-
teria isolates and 108 phage isolates were collected along the
individual phage co-evolution experiment.
Individual Phage Evolution Experiment
In this experiment, the evolving phages V1G, V1P1, and
V1P2 were cultured with a non-evolving Vibrio sp. CV1. As
for the co-evolution experiment, six replicated microcosms
(25-ml glass vials containing 6 ml of LB broth) were initially
inoculated with 106 cells of Vibrio sp. CV1 and 107 viral
particles of each phage separately and statically incubated at
30 °C for a total period of 12 days. In opposition to the co-
evolution experiment, at each transfer (after 48 h of growth),
the evolving phages were isolated from its contemporary
bacteria, and 60 μl of phage culture was transferred into fresh
media containing the ancestral bacterial host (Vibrio sp. CV1,
from the beginning of the experiment), thus preventing co-
evolution to happen. This experiment would allow obtaining
distinct evolved phages to evaluate their infectivity relative to
the co-evolution experiment, therefore controlling for the
confounding effects of the evolution of infectivity due either
by drift or by adaptation to the abiotic conditions from
changes actually driven by co-evolution (i.e., presence of an
evolving host [23]). Bacteria and phages were isolated at each
transfer and preserved as for the co-evolutionary experiment
to perform resistance/infection tests (described below).
Measuring Bacterial Resistance and Phage Infectivity
In order to evaluate the resistance of bacteria against phages
(which is the opposite of the infectivity of the phage), a spot
plaque technique was performed [22]. Agar plates were incu-
bated for 18 h at 30 °C, after which the presence or absence of
phage plaques was recorded; the presence of plaques indicated
bacterial susceptibility (phage infectivity), whereas the ab-
sence of plaques indicated resistance. For the three bacteria–
phage treatments, at each transfer and for each replicate,
bacterial resistance was determined as a ratio of the number
of resistant isolates to the total number of isolates tested (n =5).
Measuring Co-Evolution of Phage and Bacteria
For each bacterial isolate from the co-evolution experiment,
we assayed the resistance against phages from the same trans-
fer (contemporary, e.g., bacteria from transfer #3 against
phages from transfer #3), from phages isolated two transfers
back in time (past phages, e.g., bacteria from transfer #3
against phages from transfer #1), and against phages from
two transfers ahead in time (future phages, e.g., bacteria from
transfer #3 against phages from transfer #5). Under the influ-
ence of antagonistic co-evolution, the bacteria should be more
resistant to phages they have already met (past phages) than to
contemporary phages and should be more resistant to contem-
porary phages than to phages they have not encountered yet
(future phages) [22, 23]. The opposite is expected for phage
infectivity. To establish if antagonistic co-evolution occurred,
we performed for every transfer an analysis of the slope of
bacterial resistance against time (resistance-to-time) [39]. In
order to test for significance, a randomization test (n =18,
m =100,000) for each transfer was performed using the R
platform, considering the pairwise analysis of the time-
versus-resistance slope as a dependent variable.
Resistance to Ancestral Phage
We also assayed the susceptibility of the bacteria from each
transfer against the ancestral phage to test whether resistance
against it evolved during the experiment. This would help
evaluate how resistant the co-evolving bacterial clones were
in relation to the initial phage.
Phage Cocktail Evaluation
We performed the same set of experiments and analysis pre-
viously described, but instead of using individual phages, we
used a cocktail containing the three of them simultaneously
(V1G, V1P2, and V1P1).
Results
Resistance to Contemporary Phages
At the first transfer, resistance of Vibrio sp. CV1 against
contemporary phages depended on the phage considered
(Fig. 1a), showing low resistance to contemporary V1G,
intermediate resistance to contemporary V1P1, and high re-
sistance to contemporary V1P2. At transfer #2, after a slight
reduction in resistance against contemporary V1P2 and im-
portant increases in resistance against V1G and V1P1 relative
to transfer #1, the resistance of Vibrio sp. CV1 against the three
contemporary phages reached similarly high levels. Despite
one exception at transfer #4 (phages V1G and V1P1), the
resistance of co-evolving Vibrio sp. CV1 to all contemporary
phages remained high for the rest of the experiment reaching
levels of complete resistance at transfers #5 and #6.
Co-Evolutionary Dynamics
Evidence of antagonistic co-evolutionary patterns when using
individual phages was rather scarce (resistance-to-time slopes
not different from zero, Fig. 1a). No evidence of arms
race patterns was observed for phages V1P1 and V1G at any
stage of the experiment. The only evidence of antagonistic
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co-evolutionary dynamics came from the first three transfers
when using phage V1P2 for which we observed a negative
resistance-to-time slope at transfer #1 (bacteria more resistant
to contemporary than to future phage). A positive resistance-
to-time slope (bacteria more resistant to future than to con-
temporary or past phage) was observed at transfers #2 and #3
when using phage V1P2.
Resistance to Ancestral Phages
When tested against the ancestral strains of V1G, V1P1, and
V1P2, we found that at the first transfer, the resistance of
co-evolved Vibrio sp. CV1 ranged from low to intermediate,
depending on the phage (Fig. 1b). Resistance to all three
ancestral phages increased during the co-evolution experiment
and reached 100 % resistance levels at the fourth transfer
(8 days of co-evolution, Fig. 1b), though increase of resistance
over time against ancestral V1P2 was more gradual than
resistance against ancestral V1P1 and specially V1G, which
abruptly increased at transfer #2.
Evolutionary Dynamics
When confronted to non-evolving bacteria, the temporal dy-
namics of infectivity of the three individual phages presented
rather similar patterns (Fig. 2). After an initial increase in
infectivity that lasted either only one (V1P1) or two transfers
(V1G and V1P2), the infectivity of all the three evolving
phages decreased. The infectivity of V1P1 abruptly decreased
at transfer #3 and maintained very low values for the rest of
the experiment. The infectivity of evolving V1G and V1P2
against non-evolving bacteria also decreased over time, but
was higher than the infectivity of V1P1 by the end of the
experiment.
Resistance to the Phage Cocktail
When the bacteria Vibrio sp. CV1 co-evolved with the phage
cocktail that included the three phages, its resistance against
contemporary phages remained relatively low and stable dur-
ing all the experiment (Fig. 3a). Co-evolving bacteria were
1 2 3 4 5 6
0.25
0.50
0.75
1.00
P C F P C F P C F P C F P C F P C F
Time
R
e
si
st
an
ce Phage
V1G
V1P1
V1P2
Transfera
0
0.25
0.5
0.75
1
1 2 3 4 5 6
Transfer
R
es
is
ta
nc
e Phage
V1G
V1P1
V1P2
b
Fig. 1 Co-evolutionary
dynamics of Vibrio sp. CV1
resistance against individual
phages V1G (black squares),
V1P1 (gray circles), and V1P2
(light gray triangles). a At each
transfer, the mean bacterial
resistance was evaluated against
phages from two transfers back in
time (P), against contemporary
phages (C), and against phages
from two transfers ahead in the
future (F). Co-evolutionary
change is detected by exploring
the patterns in the slope formed
between resistance to future and
contemporary phages, and
between resistance to
contemporary and past phages at
each transfer. The alpha symbol
corresponds to a level of
significance of p <0.05 for the
slope pattern at each transfer.
Only V1P2 has a slope
significantly different than 0 in
transfers 1, 2, and 3. For transfers
1 and 2, the phages from two
transfers back were not available.
Vertical lines represent standard
errors. b Resistance of co-
evolved bacteria against the
ancestral phage
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often more susceptible (less resistant) to future phages than
to phages from the past (i.e., transfers #1, #3, and #5 show a
negative slope, significantly different from 0, p <0.05, Fig. 3a),
revealing the signature pattern of antagonistic co-evolution.
The co-evolved bacteria remained a low resistance against
any of the three ancestral phages along all the experiments
(Fig. 3b). When only the phages but not the bacteria were
allowed to evolve, infectivity levels of the cocktail remained
high during all the experiment (low bacterial resistance, Fig. 4).
Discussion
This study was designed to evaluate the co-evolutionary in-
teractions of the lytic phages V1G, V1P1, and V1P2, and their
natural host, the bacteria Vibrio sp. CV1. Despite some slight
differences in the temporal dynamics of infectivity among the
phages, our experiments revealed a rapid increase in the
frequency of resistant bacteria to all three individual phages
(Fig. 1a). The bacteria that evolved resistance during the co-
evolution experiment remained resistant against the ancestral
phage strains, suggesting that resistance to the co-evolving
phage population also conferred resistance to the ancestral
phage (Fig. 1b). The data collected from the evolution exper-
iment, in which the bacteria were not allowed to evolve,
revealed that the infectivity of the individual phages decreased
over time (Fig. 2). This suggests that in addition to the rapid
evolution of bacterial resistance observed in the co-evolution
treatment, co-evolved phages may have also evolved low
infectivity throughout the experiment. Therefore, the evolution
of bacterial resistance and lower phage infectivity together
contributed to the absence of co-evolutionary patterns ob-
served here (Fig. 1a). Under the evolution of bacterial resis-
tance alone, one would expect that the bacteria will be more
resistant to the past than to the future phages (negative
resistance-to-time slopes). Under the evolution of lower infec-
tivity alone, one would expect that the bacteria will be more
resistant to the phages from the future than to the phages from
the past (positive resistance-to-time slopes).
The emergence of resistance against single phages has
already been reported in other aquaculture systems [41, 42]
including for the genus Vibrio [43]. Bacterial resistancemech-
anisms against bacteriophages aim to disrupt a crucial step of
infection. These include (1) receptor modifications to prevent
adsorption, (2) superinfection systems which inhibit DNA
entry, (3) restriction–modification complexes to block invad-
ing genetic material, (4) the CRISPR-Cas loci which specifi-
cally target a sequence of the invading genetic material by
activating a complex repertoire of small RNA fragments, and
(5) abortive systems that destroy an infected cell after infec-
tion is successful [28, 44–46] [reviewed by 47]. While we
have no information allowing us to directly contrast these
mechanisms, the fact that none of the phages regained infec-
tivity suggests that resistant bacteria may modify or even
dispose the receptor involved in the interaction with each
phage alone. Additionally, the fact that the evolution of resis-
tance against contemporary phages was not accompanied by a
cost against the ancestral phage is in accordance with this
hypothesis. Noteworthy, having a CRISPR-Cas locus would
also explain the dynamics we observed in our data.
We were somehow surprised by the incapacity of the
phages to re-infect their host, considering previous reports of
an increase of infectivity over short evolutionary scales against
a single host [23, 40, 47]. However, the fact that infectivity
decreased over time in the evolution treatment suggests that
lower infectivity may have also been selected and would help
explain the incapacity of the phages to regain infectivity in the
co-evolution treatment. It has been suggested that the evolu-
tion of phage infectivity is shaped by the presence of a strong
trade-off between virulence (e.g., infectivity) and reproduction
[47]. Viruses with low virulence as the ones observed here
may be stably maintained by having high reproductive ca-
pacity. Furthermore, a mathematical model suggests that the
evolutionary stable (ES) level of parasite virulence is also
affected by the proportion of resistant host present [48]. As
the resistant population remains high, the ES of the pathogen
is significantly reduced. Noteworthy, in the case where host
resistance is allowed to co-evolve with parasite virulence, it
has been observed that parasite infectivity is even further
reduced [48].
Previous studies have revealed the importance of co-
evolution in terms of co-existence, population differentiation,
and molecular evolution [21–25, 27, 49–51]. For instance,
Buckling and Rainey [22] observed a time-lagged co-
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Fig. 2 Mean infectivity of evolved phages V1G (black squares), V1P1
(gray circles), and V1P2 (light gray triangles) at each transfer against
contemporary Vibrio sp. CV1. Vertical lines represent standard errors
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evolution when Pseudomonas fluorescens SBW25 was
confronted to its lytic phage SBW25Φ2. In that system, sev-
eral cycles of resistant and susceptible bacteria were obtained
followed by different infectious and non-infectious phages,
allowing the long-term co-existence of the phage and its host
bacteria. In accordance with our results, resistance to contem-
porary phages reached high levels after only a few transfers;
but contrary to our findings, phages were able to regain
infectivity. The observed incapacity of the mentioned phages
to maintain or regain infectivity supposes a strong limitation
for their persistence [49, 52]. A possible explanation for the
persistence of the phages despite their extremely low infectiv-
ity is that some sensitive bacteria were still present in low
frequencies, allowing the phage to reproduce [52, 53]. In fact,
this has been shown in long-term experiments for the co-
evolutionary dynamics of Escherichia coli with the T4 [28]
and the RNA Qβ lytic phages [54]. Stable co-existence was
observed between resistant and sensitive populations of the
host, as well as for T4. Mainly, when spontaneous resistant
mutants rose, both the susceptible and resistant populations
co-existed at similar levels, while phages increased their
numbers only after prolonged seasons at low densities [28].
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Fig. 3 Co-evolutionary changes
in Vibrio sp. CV1 resistance
against the phage cocktail
composed of V1G, V1P1, and
V1P2. a At each transfer, the
mean bacterial resistance was
evaluated against phages from two
transfers back in time (P), against
contemporary phages (C), and
against phages from two transfers
ahead in the future (F). The co-
evolutionary change is detected by
exploring the patterns in the slope
formed between future and
contemporary phages, and
between contemporary and past
phages at each transfer. b
Resistance of co-evolved bacteria
against each of the three ancestral
phages. Asterisk corresponds to a
level of significance of p<0.05 for
the slope pattern at each transfer.
For transfers 1 and 2, the phages
from two transfers back were not
available. Plus sign indicates the
significance level of the difference
of the mean resistance proportion
between the phage cocktail
treatment and the single-phage
treatments: p<0.05=single plus
sign , p<0.01=double plus sign .
and p<<0.001=triple plus sign .
Vertical lines represent standard
errors
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Co-existence was also observed in long-term evolution with
Qβ [54]. In this case, E. coli showed partial resistance follow-
ed by stepwise improvements in growth rate. Conversely, Qβ
counter adapted by increasing release efficiency and decreas-
ing virulence [54]. Furthermore, whole-genome analysis
showed accelerated evolution, despite differences in genome
size and mutation rates, in both host and the phage, allowing
co-existence [54].
In opposition to monophage treatments, the use of a phage
cocktail avoided Vibrio sp. CV1 to evolve resistance, and
average resistance levels against the phage cocktail were
much lower compared to any of the monophage treatments
(Fig. 1a vs. Fig. 3a). Additionally, in the presence of three
phages, the co-evolving bacteria did not become resistant
against the ancestral phages (Fig. 3b). These results are in
accordance with the mounting evidence of phage cocktails
delaying the emergence of resistance compared to monophage
therapy in E. coli [16, 34], Vibrio cholerae [43], Pseudomonas
aeruginosa [39], Salmonella sp. [37], and Klebsiella
pneumoniae [17]. Although some resistant bacteria may
also evolve when a cocktail is used, a much longer time is
needed to accumulate enoughmutations to develop resistance.
Reductions in bacterial cell densities using a cocktail may
result in lower mutation rates, thus limiting the potential for
bacterial resistance evolution. Altogether, our results indicate
that the incapacity of bacteria to evolve resistance in presence
of the phage cocktail is in fact due to the diversity of the
phages since none of them could individually account for the
observed high infectivity levels by itself. Perhaps the most
original finding of our study is that the presence of multiple
phages resulted in a pattern of antagonistic co-evolution, with
Vibrio sp. CV1 being more sensitive to phages never encoun-
tered before than to past or contemporary phages. This pattern
contrasted with the three monophage treatments in which
antagonistic co-evolution patterns were absent and suggested
a permanent arms race between the bacteria developing resis-
tance and the phage cocktail overcoming those defenses. In a
recent effort to overcome the emergence of bacterial resistance
against phages, Gu and colleagues [17] performed what they
called a “step-by-step” approach to isolate three phages that
together formed a very effective phage cocktail to fight against
K. pneumoniae infections in mice. The principle of this meth-
od was to track the emergence of resistant bacteria over time
and to isolate infectious phage for each newly emerged resis-
tant bacteria. As a result, because the three phages targeted
different hosts, the phage cocktail delayed the emergence of
resistance and increased mice survival. In accordance with the
observed delay in the emergence of resistance when a cocktail
was used, it is possible that our three phages are targeting
different bacterial genotypes present in the culture. This sug-
gests that the emergence of resistance in the presence of
multiple phages, which requires the modification of multiple
receptors, may represent a higher cost than developing resis-
tance against a single phage [40, 55].
We acknowledge some limitations in the present work.
First, our study was limited to the exploration of the outcome
of co-evolution. We did not consider the genetic aspects of
resistance acquisition or of infectivity. Future research should
not only focus on the trends, such as the ones mentioned here,
but should also explore the underlying mechanisms. We also
believe that the results presented here require validation under
natural conditions. For instance, experiments need to be
performed in the field, where the influence of other biotic
and abiotic factors may modify the resistance of bacteria or
the infectivity of the phages and hence alters the success of
phage therapy in terms of shrimp survival, though, we still
believe our results are promising in terms of their conse-
quences to different industrial or medical scenarios. At pres-
ent, the design of phage cocktails with antimicrobial purposes
is entering a new era on its development by incorporating
different methods of phage isolation [17] and exposition [39].
Our data underline the importance of also exploring the dy-
namics of co-evolution when considering phages for bacterial
control, in particular because the acquisition of resistance may
be accompanied by the incapacity of phage to regain infectiv-
ity. An important conclusion from our study is that due to the
rapid emergence of bacterial resistance and the incapacity of
phages to regain infectivity, phage therapy using a single
phage may be an inefficient treatment against vibriosis in
shrimp hatcheries. As an interesting perspective, given the
limited capacity of bacteria to develop resistance against a
phage cocktail [17, 37–40], simultaneously using multiple
phages may represent a more effective strategy for the control
of bacterial infections. Our study provides valuable informa-
tion corroborating the recent evidence in favor of the utiliza-
tion of phage cocktails.
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Fig. 4 Mean infectivity of evolved phages at each transfer against
contemporary Vibrio sp. CV1. Vertical lines represent standard errors
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